Skip to main content
JIANGSU SIHUAN BIOENGINEERING CO.,LTD logo

JIANGSU SIHUAN BIOENGINEERING CO.,LTD — Investor Relations & Filings

Ticker · 000518 ISIN · CNE0000001P8 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,779 across all filing types
Latest filing 2025-06-13 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 000518

About JIANGSU SIHUAN BIOENGINEERING CO.,LTD

https://www.000518shsw.com

Jiangsu Sihuan Bioengineering Co., Ltd. specializes in the research, development, and production of biopharmaceutical products and traditional Chinese medicines. The company’s core product line features genetic engineering drugs, including recombinant human interleukin-2 (rhIL-2) and recombinant human granulocyte colony-stimulating factor (rhG-CSF). Its manufacturing capabilities encompass various dosage forms such as injections, capsules, and tablets, adhering to rigorous quality standards. In addition to its pharmaceutical core, the company manages ecological restoration and landscape engineering initiatives. The organization focuses on leveraging biotechnology to provide therapeutic solutions for oncology and immune-related conditions, maintaining a commitment to scientific innovation and clinical efficacy.

Recent filings

Filing Released Lang Actions
江苏四环生物股份有限公司关于公司财务总监辞职暨聘任财务总监的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the resignation of the company's financial director and the appointment of a new financial director. It includes details about the resignation, appointment, and related board resolutions. There are no financial statements, earnings data, or detailed financial analysis present. The document is a formal announcement of management changes, specifically in senior management positions, which fits the category of Board/Management Information (MANG). The document length is short and it does not contain or reference a full report, so it is not an Annual Report or Interim Report. Therefore, the correct classification is MANG with high confidence.
2025-06-13 Chinese
江苏四环生物股份有限公司第十届董事会第十五次会议决议公告
Board/Management Information Classification · 100% confidence The document is an announcement of a board meeting resolution by Jiangsu Sihuan Bio Co., Ltd. It details the appointment of a new financial director, including the meeting date, attendance, and compliance with company law and listing rules. It references another announcement about the resignation and appointment of the financial director. The content focuses on board/management changes rather than financial results, audit, or other report types. The document length is short and it is clearly a formal announcement of management changes, fitting the Board/Management Information category.
2025-06-13 Chinese
江苏四环生物股份有限公司关于股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by Jiangsu Sihuan Bio Co., Ltd. regarding abnormal stock price fluctuations over three consecutive trading days. It includes details about the stock code, trading price changes, company statements confirming no undisclosed material information, and references to prior announcements about delisting risk warnings. The document is short (1234 characters) and serves as a regulatory disclosure about stock trading anomalies and risk warnings, not a financial report or detailed analysis. It fits the category of a Regulatory Filing (RNS) as it is a compliance announcement related to stock trading and disclosure obligations under Shenzhen Stock Exchange rules, rather than a full report or earnings release.
2025-06-11 Chinese
江苏四环生物股份有限公司关于2025年第三次临时股东大会增加临时提案暨股东大会补充通知的公告
Proxy Solicitation & Information Statement Classification · 95% confidence The document is an announcement regarding the addition of a temporary proposal to the agenda of the company's 2025 third extraordinary general meeting of shareholders (临时股东大会). It details the meeting date, voting methods, proposals to be discussed, and procedural information for shareholders. It does not contain financial statements or detailed financial analysis, nor is it a transcript or presentation. It is a formal notice about the shareholder meeting and its agenda, including voting instructions and proxy forms. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or Proxy Solicitation & Information Statement (PSI). However, since it is a notice about the meeting and proposals (including voting instructions) rather than the actual voting results or a proxy solicitation document, it aligns best with Proxy Solicitation & Information Statement (PSI). The document length is 4236 characters, which is typical for such notices. Therefore, the classification is PSI with high confidence.
2025-06-06 Chinese
江苏四环生物股份有限公司独立董事2025年第二次专门会议审核意见
Board/Management Information Classification · 95% confidence The document is a formal opinion from independent directors regarding a specific related-party transaction of a subsidiary, referencing regulatory rules and internal governance procedures. It is not a full financial report, earnings release, or management discussion. It is also not an announcement of voting results or a meeting presentation. The content aligns with a governance-related document, specifically related to board or management information about internal approvals and oversight. The document length is short and focused on a specific governance matter, fitting best under Board/Management Information (MANG).
2025-06-06 Chinese
江苏四环生物股份有限公司第十届董事会第十四次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of the resolutions passed at the 14th meeting of the 10th Board of Directors of Jiangsu Sihuan Biological Co., Ltd. It details the meeting date, attendance, and voting results on a related party transaction proposal. There is no financial data or comprehensive report content, only a summary of board decisions. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors. The document length is short and it is not a full report or financial statement.
2025-06-06 Chinese

Browse filings by year

29 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.